Reprogramming tumor-associated macrophages using STING or TLR agonists: a promising strategy to enhance immunotherapy in hormone-dependent cancers

Reprogramming tumor-associated macrophages using STING or TLR agonists: a promising strategy to enhance immunotherapy in hormone-dependent cancers

Hormone-dependent cancers, like breast and prostate cancers, represent a unique challenge in oncology due to their complex interplay between hormone signaling, immune evasion, and therapeutic resistance. While endocrine therapies effectively target hormone signaling to initially control disease, res...

Full description

Saved in:
Bibliographic Details
Main Authors: Rosario Garcia-Campelo, Fernando Torres Andón, Victor Sacristan Santos, Alba Pensado-López, Silvia Antolin Novoa, Rosa Señaris Rodriguez
Format: Article
Language:English
Published: BMJ Publishing Group 2025-05-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/13/5/e010950.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items